Γ—

Steve Hill

About Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine. Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.

Related Organizations

Articles from this author

Nu-Journal Club logo
The Journal Club returns with Dr. Oliver Medvedik on September 26th at 12:00 Eastern time on our Facebook page. We take a look at a recent study published in Nature, in which extracellular vesicles derived from neonatal cardiac progenitors produced significant rejuvenation in old rats and human cells. Abstract Rejuvenation of an old organism was...
Nu-Journal Club logo
The Journal Club returns with Dr. Oliver Medvedik on September 26th at 12:00 Eastern time on our Facebook page. We take a look at a recent study published in Nature, in which extracellular vesicles derived from neonatal cardiac progenitors produced significant rejuvenation in old rats and human cells. Abstract Rejuvenation of an old organism was...
An image of telomeres shortening which could lead to DNA damage.
Since its launch in 2016, Rejuvenation Technologies, located in Mountain View, California, has been developing a therapeutic to restore telomeres in humans. The company has been in stealth mode for a number of years, but there is finally some news! Reversing a decade of telomere loss in one treatment Rejuvenation Technologies has created a method...
Liar at table
We are at an interesting time for our field, and at long last, some rejuvenation therapies are entering clinical trials. The approach of directly targeting the processes of aging in humans can finally be put to the test. While rejuvenation therapies that aim to prevent, stop, or even reverse aging and age-related diseases are gradually...
Impetus grants are designed to be easy and fast to apply for.
Earlier this month, Impetus Grants announced its third round of funding, with 10 million from the Rosenkranz and Hevolution foundations. Previously, the program conducted two grant rounds, bringing 114 new projects and 50 new labs into the space, giving away more than 24 million dollars for a β€œnew kind of science”. Now, some of these...
Lobster
  "Could humans become immortal?" is something we get asked quite often, and the answer depends on what exactly you mean. When it comes to immortality, what you mean is important Whether human immortality is possible greatly depends on how you define it. If you define it as living forever and being unkillable like in...